2023
DOI: 10.1016/j.matdes.2023.111749
|View full text |Cite
|
Sign up to set email alerts
|

Immobilizing enoxacin on implant by polyvinyl butyral coating to promote osseointegration in osteoporosis with infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 56 publications
0
2
0
Order By: Relevance
“…Therefore, surface modification of PEEK has become one of the challenges for clinical applications [ 13 ]. This is a way to enhance bioactivity without impacting its overall structure and properties [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, surface modification of PEEK has become one of the challenges for clinical applications [ 13 ]. This is a way to enhance bioactivity without impacting its overall structure and properties [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…According to reports, enoxacin (ENX) can inhibit RANKL-induced JNK signaling to reduce osteoclast generation. Bai et al (2023) used polyvinyl butyral (PVB) as the coating medium to modify SPEEK with ENX (SPEEK/PVB-ENX*3). The research found that SPEEK/PVB-ENX*3 can weaken the ability of macrophages co-cultured with the RANKL-inducing factor to fuse into multinucleated osteoclasts.…”
Section: Modification For Enhanced Biopropertiesmentioning
confidence: 99%